Basel Medical Group Ltd (BMGL)

NASDAQ: BMGL · Real-Time Price · USD

0.5483

-0.0416 (-7.05%)

At close: Jun 2, 2026, 4:00 PM EDT

0.4158

-0.1325 (-24.17%)

Pre-market: Jun 3, 2026, 8:36 AM EDT

Basel Medical Group Cash Flow Statement

Financials in millions SGD. Fiscal year is July - June.

Millions SGD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Net Income	-11.05	2.4	2.13	2.39
Depreciation & Amortization	1.18	0.53	0.56	0.58
Other Adjustments	11.64	0.17	0.15	0.1
Change in Receivables	-8.69	-0.42	0.54	0.01
Changes in Inventories	-0.3	0.02	-0.02	0
Changes in Accounts Payable	4.03	0.39	-0.22	0.06
Changes in Income Taxes Payable	-0.65	-0.18	-0.29	-0.03
Changes in Other Operating Activities	-0.2	-0.41	-0.24	-0.32
Operating Cash Flow	-4.04	2.51	2.6	2.79
Operating Cash Flow Growth	-	-3.49%	-6.89%	-
Capital Expenditures	-0.56	-0.01	-0.01	-0.09
Payments for Business Acquisitions	-10.34	-	-	-
Investing Cash Flow	-10.9	-0.01	-0.01	-0.09
Long-Term Debt Issued	4	-	-	1.03
Long-Term Debt Repaid	-9.58	-2.92	-2.94	-3.09
Net Long-Term Debt Issued (Repaid)	-5.58	-2.92	-2.94	-2.06
Issuance of Common Stock	9.75	-	-	-
Net Common Stock Issued (Repurchased)	9.75	-	-	-
Other Financing Activities	12.33	1.16	0	-10.86
Financing Cash Flow	16.5	-1.77	-2.94	-12.92
Effect of Exchange Rate Changes on Cash and Cash Equivalents	-0.46	-	-	-
Net Cash Flow	1.56	0.73	-0.35	-10.22
Free Cash Flow	-4.6	2.5	2.59	2.7
Free Cash Flow Growth	-	-3.56%	-4.07%	-
FCF Margin	-40.64%	24.89%	26.74%	25.37%
Free Cash Flow Per Share	-0.24	0.15	0.16	0.17
Levered Free Cash Flow	-12.72	-0.51	-1.38	0.53
Unlevered Free Cash Flow	-8.63	2.17	1.74	2.36

SEC Filings: 10-K · 10-Q